LOADING
Tag: Dupilumab
Baricitinib Effective in Atopic Dermatitis Patients who Failed Dupilumab
September 29, 2022
New research shows baricitinib could be an effective treatment option for patients with atopic dermatitis who do not respond to dupilumab. A team, led by Linde de Wijs, Department of Dermatology, Erasmus MC University Medical Center, evaluated the effectiveness and safety of baricitinib treatment in daily practice for patients with atopic dermatitis who have inadequately responded […]
chat_bubble0 Comment
visibility333 Views
Dupilumab Promising Long Term for Atopic Dermatitis in Adolescents
July 11, 2022
Dupilumab had an acceptable long-term safety and efficacy for adolescents with moderate to severe atopic dermatitis (AD), according to data from an open-label extension (OLE) phase 3 trial published in the American Journal of Clinical Dermatology. For adolescents (aged 12 to 18 years) with moderate to severe AD enrolled in the LIBERTY AD PED-OLE study, […]
chat_bubble0 Comment
visibility441 Views